Last update 21 Nov 2024

Amlodipine Besylate/Rosuvastatin Calcium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Amlodipine/rosuvastatin, Rosuvastatin/amlodipine
+ [1]
Target
HMG-CoA reductase x VDCCs
Mechanism
HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), VDCCs blockers(Voltage-gated calcium channel blockers)
Therapeutic Areas
Cardiovascular DiseasesEndocrinology and Metabolic Disease
Active Indication-
Inactive Indication
HypercholesterolemiaHypertension
Originator Organization
GSK PlcGSK Plc
Active Organization-
Inactive Organization
Alvogen Korea Co., Ltd.
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC26H31ClN2O8S
InChIKeyZPBWCRDSRKPIDG-UHFFFAOYSA-N
CAS Registry111470-99-6
View All Structures (2)

Related

4
Clinical Trials associated with Amlodipine Besylate/Rosuvastatin Calcium
NCT06293261 / Active, not recruitingNot Applicable
Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia
NCT02955368 / WithdrawnPhase 3
A Multi-center, Randomized, Double-blind, Parallel-group Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R212 Fixed Dose Combination in Patients With Dyslipidemia and Hypertension
NCT02814500 / Unknown statusPhase 1
DP-R212 Pharmacokinetic Study Pharmacokinetic Characteristics of DP-R212 in Comparison to Each Component Coadministered in Healthy Volunteers
100 Clinical Results associated with Amlodipine Besylate/Rosuvastatin Calcium
Login to view more data
100 Translational Medicine associated with Amlodipine Besylate/Rosuvastatin Calcium
Login to view more data
100 Patents (Medical) associated with Amlodipine Besylate/Rosuvastatin Calcium
Login to view more data
100 Deals associated with Amlodipine Besylate/Rosuvastatin Calcium
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HypercholesterolemiaPhase 3-
Alvogen Korea Co., Ltd.
01 Feb 2017
HypertensionPhase 3-
Alvogen Korea Co., Ltd.
01 Feb 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free